Approximately 40% of patients receiving the maximum tolerated dose (MTD) of docetaxel were hospitalised for neutropenia despite administration of granulocyte colony-stimulating factor (G-CSF) d5–10 and ciprofloxacin d5–15 (Colevas et al, 1998). Here, CSF3 is linked to neutropenia.